Showing results (1-10 of 25) with videos related to
Sort By:
Pageof 3
Cancer Management and Research|May 21, 2021
Chemotherapy-Free Management of Follicular and Marginal Zone LymphomaThomas A Ollila, Adam J OlszewskiCurrent Treatment Options in Oncology|June 23, 2018
Extranodal Diffuse Large B Cell Lymphoma: Molecular Features, Prognosis, and Risk of Central Nervous System RecurrenceThomas A Ollila, Adam J OlszewskiCancer Management and Research|September 13, 2023
Advances in Immunotherapy for the Treatment of Cutaneous T-Cell LymphomaAri Pelcovits, Thomas A Ollila, Adam J OlszewskiOncotargets and Therapy|February 26, 2019
Mogamulizumab: a new tool for management of cutaneous T-cell lymphomaThomas A Ollila, Ilyas Sahin, Adam J OlszewskiFrontiers in Oncology|May 3, 2024
Immune checkpoint inhibitors in advanced and relapsed/refractory Hodgkin lymphoma: current applications and future prospectsCharles J Milrod, Ari Pelcovits, Thomas A OllilaLeukemia & Lymphoma|July 10, 2019
Clinical features and survival of patients with T-cell/histiocyte-rich large B-cell lymphoma: analysis of the National Cancer Data BaseThomas A Ollila, John L Reagan, Adam J OlszewskiBlood Advances|July 17, 2023
Immunochemotherapy or chemotherapy alone in primary central nervous system lymphoma: a National Cancer Database analysisThomas A Ollila, Rashida Taher, Prashanth Moku, et al.The Oncologist|April 21, 2020
Molecular Profiles of Brain and Pulmonary Metastatic Disease in Cancer of Unknown PrimaryBrianna R Bakow, Christopher P Elco, Mark LeGolvan, et al.The Lancet. Haematology|April 2, 2025
Quality-of-life endpoints collection, reporting, and framing in randomised trials of indolent lymphomas: a systematic reviewCharles J Milrod, Lila Rubin, Boris Martinez, et al.British Journal of Haematology|April 4, 2024
Progression-free survival is a weakly predictive surrogate end-point for overall survival in follicular lymphoma: A systematic review and meta-analysisCharles J Milrod, Kang Woo Kim, Christina Raker, et al.Pageof 3